This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Ju-Hee Lee
Introduction
Ju-Hee Lee is a prominent inventor based in Daegu, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. Her innovative work has garnered attention for its potential impact on cancer therapies.
Latest Patents
Ju-Hee Lee holds a patent for a Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer. This invention includes a compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof. The compound exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), making it a promising candidate for cancer treatment.
Career Highlights
Ju-Hee Lee is associated with Omic Smap Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to finding effective solutions for complex health challenges, particularly in oncology.
Collaborations
Some of her notable coworkers include Jung Jin Hwang and Sang Eun Park. Their collaborative efforts contribute to the innovative environment at Omic Smap Inc., fostering advancements in cancer research.
Conclusion
Ju-Hee Lee's contributions to cancer treatment through her patented innovations highlight her role as a key figure in pharmaceutical research. Her work not only showcases her expertise but also holds the potential to significantly impact cancer therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile